Biodesix Inc (BDSX) stock
BDSXNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$8.40−0.48 (-5.41%)
Close on Nov 18, 2026Market cap $88.63MP/E –Yield –
Biodesix shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Biodesix's shares outstanding was 10M at Jun 30, 2026. For fiscal 2025 it was 8M, up 16.7% from the year before. The highest annual figure on record is 82M in fiscal 2023.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8M | +16.7% |
| FY2024 | Dec 31, 2024 | 6M | -92.1% |
| FY2023 | Dec 31, 2023 | 82M | +95.0% |
| FY2022 | Dec 31, 2022 | 42M | +53.9% |
| FY2021 | Dec 31, 2021 | 27M | +465.6% |
| FY2020 | Dec 31, 2020 | 5M | +1899.2% |
| FY2019 | Dec 31, 2019 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 10M | +40.4% |
| Q1 FY2026 | Mar 31, 2026 | 10M | +32.3% |
| Q4 FY2025 | Dec 31, 2025 | 8M | +10.0% |
| Q3 FY2025 | Sep 30, 2025 | 8M | +2.5% |
| Q2 FY2025 | Jun 30, 2025 | 7M | -94.2% |
| Q1 FY2025 | Mar 31, 2025 | 7M | -92.5% |
| Q4 FY2024 | Dec 31, 2024 | 7M | -92.1% |
| Q3 FY2024 | Sep 30, 2024 | 7M | -90.8% |
| Q2 FY2024 | Jun 30, 2024 | 127M | +62.0% |
| Q1 FY2024 | Mar 31, 2024 | 97M | +24.9% |
| Q4 FY2023 | Dec 31, 2023 | 92M | +60.6% |
| Q3 FY2023 | Sep 30, 2023 | 80M | +97.1% |
| Q2 FY2023 | Jun 30, 2023 | 79M | +100.1% |
| Q1 FY2023 | Mar 31, 2023 | 78M | +150.3% |
| Q4 FY2022 | Dec 31, 2022 | 58M | +112.7% |
| Q3 FY2022 | Sep 30, 2022 | 40M | +44.2% |
| Q2 FY2022 | Jun 30, 2022 | 39M | +1457.0% |
| Q1 FY2022 | Mar 31, 2022 | 31M | +16.8% |
| Q4 FY2021 | Dec 31, 2021 | 27M | +9668.6% |
| Q3 FY2021 | Sep 30, 2021 | 28M | +10100.4% |
| Q2 FY2021 | Jun 30, 2021 | 3M | +865.6% |
| Q1 FY2021 | Mar 31, 2021 | 27M | +9790.0% |
| Q3 FY2020 | Sep 30, 2020 | 0M | +13.5% |
| Q2 FY2020 | Jun 30, 2020 | 0M | – |
| Q1 FY2020 | Mar 31, 2020 | 0M | – |
| Q4 FY2019 | Dec 31, 2019 | 0M | – |
| Q3 FY2019 | Sep 30, 2019 | 0M | – |
See a number that looks wrong?